Clinical trials have shown that laboratory aspirin resistance is correlated with vascular events.
多项临床试验证实，实验室阿司匹林抵抗和临床血管事件相关。
Objective To explore the clinical signi fi cance of CAP changes and the management of aspirin resistance in CHD patients.
目的探讨冠心病患者循环活化血小板（CAP）的变化及对阿斯匹林抵抗的处理。
ABSTRACT: aspirin is an important antithrombotic agent. However, its clinical benefit is impaired by aspirin resistance.
摘要：阿司匹林是抗血栓治疗的重要药物，阿司匹林抵抗是影响其疗效的常见原因。
应用推荐